Schröder CP - Search Results

1

⁸⁹Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer.

Bensch F, van der Veen EL, Lub-de Hooge MN, Jorritsma-Smit A, Boellaard R, Kok IC, Oosting SF, Schröder CP, Hiltermann TJN, van der Wekken AJ, Groen HJM, Kwee TC, Elias SG, Gietema JA, Bohorquez SS, de Crespigny A, Williams SP, Mancao C, Brouwers AH, Fine BM, de Vries EGE. Bensch F, et al. Among authors: schroder cp. Nat Med. 2018 Dec;24(12):1852-1858. doi: 10.1038/s41591-018-0255-8. Epub 2018 Nov 26. Nat Med. 2018. PMID: 30478423 Clinical Trial.

2

Weakness and numbness after chemotherapy for metastatic non-seminoma testis: a new neurological complication.

Verdonk RC, Enting RH, Janmaat M, Schroder CP, Sleijfer DT, Gietema JA. Verdonk RC, et al. Among authors: schroder cp. Acta Oncol. 2008;47(8):1596-8. doi: 10.1080/02841860701877330. Acta Oncol. 2008. PMID: 18607855 No abstract available.

3

Trastuzumab pharmacokinetics influenced by extent human epidermal growth factor receptor 2-positive tumor load.

Oude Munnink TH, Dijkers EC, Netters SJ, Lub-de Hooge MN, Brouwers AH, Haasjes JG, Schröder CP, de Vries EG. Oude Munnink TH, et al. Among authors: schroder cp. J Clin Oncol. 2010 Jul 20;28(21):e355-6; author reply e357. doi: 10.1200/JCO.2010.28.4604. Epub 2010 May 10. J Clin Oncol. 2010. PMID: 20458048 No abstract available.

4

PET with the 89Zr-labeled transforming growth factor-β antibody fresolimumab in tumor models.

Oude Munnink TH, Arjaans ME, Timmer-Bosscha H, Schröder CP, Hesselink JW, Vedelaar SR, Walenkamp AM, Reiss M, Gregory RC, Lub-de Hooge MN, de Vries EG. Oude Munnink TH, et al. Among authors: schroder cp. J Nucl Med. 2011 Dec;52(12):2001-8. doi: 10.2967/jnumed.111.092809. Epub 2011 Nov 9. J Nucl Med. 2011. PMID: 22072706 Free article.

5

Zirconium-89-trastuzumab positron emission tomography as a tool to solve a clinical dilemma in a patient with breast cancer.

Gaykema SB, Brouwers AH, Hovenga S, Lub-de Hooge MN, de Vries EG, Schröder CP. Gaykema SB, et al. Among authors: schroder cp. J Clin Oncol. 2012 Feb 20;30(6):e74-5. doi: 10.1200/JCO.2011.38.0204. Epub 2011 Dec 27. J Clin Oncol. 2012. PMID: 22203768 No abstract available.

6

Transforming growth factor (TGF)-β expression and activation mechanisms as potential targets for anti-tumor therapy and tumor imaging.

Arjaans M, Oude Munnink TH, Timmer-Bosscha H, Reiss M, Walenkamp AM, Lub-de Hooge MN, de Vries EG, Schröder CP. Arjaans M, et al. Among authors: schroder cp. Pharmacol Ther. 2012 Aug;135(2):123-32. doi: 10.1016/j.pharmthera.2012.05.001. Epub 2012 May 12. Pharmacol Ther. 2012. PMID: 22587883 Review.

7

Lapatinib and 17AAG reduce 89Zr-trastuzumab-F(ab')2 uptake in SKBR3 tumor xenografts.

Oude Munnink TH, de Vries EG, Vedelaar SR, Timmer-Bosscha H, Schröder CP, Brouwers AH, Lub-de Hooge MN. Oude Munnink TH, et al. Among authors: schroder cp. Mol Pharm. 2012 Nov 5;9(11):2995-3002. doi: 10.1021/mp3002182. Epub 2012 Oct 11. Mol Pharm. 2012. PMID: 23003202

8

Bevacizumab-induced normalization of blood vessels in tumors hampers antibody uptake.

Arjaans M, Oude Munnink TH, Oosting SF, Terwisscha van Scheltinga AG, Gietema JA, Garbacik ET, Timmer-Bosscha H, Lub-de Hooge MN, Schröder CP, de Vries EG. Arjaans M, et al. Among authors: schroder cp. Cancer Res. 2013 Jun 1;73(11):3347-55. doi: 10.1158/0008-5472.CAN-12-3518. Epub 2013 Apr 11. Cancer Res. 2013. PMID: 23580572

9

Bevacizumab-induced vessel normalization hampers tumor uptake of antibodies--response.

Arjaans M, Oosting SF, Schröder CP, de Vries EG. Arjaans M, et al. Among authors: schroder cp. Cancer Res. 2013 Dec 1;73(23):7147-8. doi: 10.1158/0008-5472.CAN-13-2532. Epub 2013 Nov 21. Cancer Res. 2013. PMID: 24265275 No abstract available.

10

HER3, serious partner in crime: therapeutic approaches and potential biomarkers for effect of HER3-targeting.

Kol A, Terwisscha van Scheltinga AG, Timmer-Bosscha H, Lamberts LE, Bensch F, de Vries EG, Schröder CP. Kol A, et al. Among authors: schroder cp. Pharmacol Ther. 2014 Jul;143(1):1-11. doi: 10.1016/j.pharmthera.2014.01.005. Epub 2014 Feb 7. Pharmacol Ther. 2014. PMID: 24513440 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

143 results

Search Page